{Reference Type}: Case Reports
{Title}: Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation.
{Author}: Herrera Siklody C;Pruvot E;Pascale P;Kinj R;Jumeau R;Le Bloa M;Teres C;Domenichini G;Porretta AP;Ozsahin M;Bourhis J;Schiappacasse L;Herrera Siklody C;Pruvot E;Pascale P;Kinj R;Jumeau R;Le Bloa M;Teres C;Domenichini G;Porretta AP;Ozsahin M;Bourhis J;Schiappacasse L;
{Journal}: Clin Transl Radiat Oncol
{Volume}: 37
{Issue}: 0
{Year}: Nov 2022
{Factor}: 4.739
{DOI}: 10.1016/j.ctro.2022.07.005
{Abstract}: <B>UNASSIGNED: </B>Stereotactic arrhythmia radioablation (STAR) is an effective treatment for refractory ventricular tachycardia (VT), but recurrences after STAR were recently published. Herein, we report two cases of successful re-irradiation of the arrhythmogenic substrate.<BR><B>UNASSIGNED: </B>We present two cases of re-irradiation after recurrence of a previously treated VT with radioablation at a dose of 20 Gy. The VT exit was localized on the border zone of the irradiated volume, which responded positively to re-irradiation at follow-up.<BR><B>UNASSIGNED: </B>These two cases show the technical feasibility of re-irradiation to control recurrent VT after a first STAR.